Genome sequencing reveals disease risk in otherwise healthy babies

By | January 3, 2019
newborn baby

Are there benefits to screening the genomes of healthy newborns?

Petri Oeschger/Getty

DNA sequencing is getting faster and cheaper, and it has been used to diagnose rare disorders in very sick children. But should it become a standard practice for healthy newborns? That’s the question asked by the BabySeq project, which has just released results from the first phase of its study.

The sequencing trial included 32 sick infants in the intensive care units at three Boston-area hospitals, and 127 healthy children enrolled through the nursery at Brigham and Women’s Hospital in Boston.

140 …

New Scientist – Home